Ligand validation:7EMO

CXS: 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7EMO_CXS_B_203	95%	25%	0.073	0.977	2.06	1.18	2	3	0	0	100%	1
7EMO_CXS_C_202	79%	21%	0.128	0.974	2.02	1.45	2	2	0	0	100%	1
7EMO_CXS_A_202	50%	9%	0.118	0.869	2.34	2.25	2	4	1	0	100%	1
7EMQ_CXS_B_304	90%	28%	0.087	0.968	1.84	1.19	2	2	0	0	100%	1
7EMP_CXS_B_204	86%	25%	0.105	0.973	1.65	1.53	2	3	0	0	100%	1
7EMR_CXS_B_204	84%	14%	0.105	0.967	2.11	1.93	2	2	0	0	100%	1
6GAL_CXS_M_604	100%	37%	0.043	0.993	1.04	1.52	1	2	0	0	100%	1
3OBL_CXS_B_134	98%	20%	0.058	0.981	2.24	1.29	2	4	0	0	100%	1
1RZL_CXS_A_201	97%	31%	0.067	0.984	1.39	1.49	2	1	0	0	100%	1
7NFZ_CXS_A_401	97%	41%	0.069	0.984	1.1	1.23	1	3	0	0	100%	1
4XFE_CXS_A_402	94%	54%	0.067	0.967	0.57	1.2	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.